Cas no 13784-17-3 (N4-methylpyrimidine-4,5-diamine)
N4-methylpyrimidine-4,5-diamine Chemical and Physical Properties
Names and Identifiers
-
- 4,5-Pyrimidinediamine,N4-methyl-
- 4,5-Pyrimidinediamine, N4-methyl- (9CI)
- 4-N-methylpyrimidine-4,5-diamine
- N4-methylpyrimidine-4,5-diamine
- N4-methyl-4,5-diaminopyrimidine
- AKOS006309189
- SCHEMBL12462179
- 13784-17-3
- N4-methylpyrimidine-4,5-diamine, AldrichCPR
- 5-amino-4-methylaminopyrimidine
- EN300-310060
-
- MDL: MFCD11046921
- Inchi: 1S/C5H8N4/c1-7-5-4(6)2-8-3-9-5/h2-3H,6H2,1H3,(H,7,8,9)
- InChI Key: KLPOQSPEGNLKIY-UHFFFAOYSA-N
- SMILES: N(C)C1C(=CN=CN=1)N
Computed Properties
- Exact Mass: 124.074896272g/mol
- Monoisotopic Mass: 124.074896272g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 9
- Rotatable Bond Count: 1
- Complexity: 85
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.2
- Topological Polar Surface Area: 63.8?2
N4-methylpyrimidine-4,5-diamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-310060-1g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 1g |
$884.0 | 2023-09-05 | |
| Enamine | EN300-310060-5g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 5g |
$2566.0 | 2023-09-05 | |
| Enamine | EN300-310060-10g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 10g |
$3807.0 | 2023-09-05 | |
| Ambeed | A1090975-1g |
N4-Methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 1g |
$641.0 | 2024-04-24 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD01067315-1g |
N4-Methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 1g |
¥4403.0 | 2023-02-27 | |
| Enamine | EN300-310060-0.05g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 0.05g |
$205.0 | 2023-09-05 | |
| Enamine | EN300-310060-0.1g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 0.1g |
$306.0 | 2023-09-05 | |
| Enamine | EN300-310060-0.25g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 0.25g |
$438.0 | 2023-09-05 | |
| Enamine | EN300-310060-0.5g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 0.5g |
$691.0 | 2023-09-05 | |
| Enamine | EN300-310060-1.0g |
N4-methylpyrimidine-4,5-diamine |
13784-17-3 | 95% | 1g |
$0.0 | 2023-06-06 |
N4-methylpyrimidine-4,5-diamine Suppliers
N4-methylpyrimidine-4,5-diamine Related Literature
-
Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
-
Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
-
Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
-
Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
Additional information on N4-methylpyrimidine-4,5-diamine
N4-methylpyrimidine-4,5-diamine: A Novel Compound with Promising Applications in Biomedical Research
N4-methylpyrimidine-4,5-diamine (CAS No. 13784-17-3) is a unique organic compound that has garnered significant attention in recent years due to its potential applications in biomedical research. This compound belongs to the class of pyrimidine derivatives, which are well-known for their diverse biological activities. The structural features of N4-methylpyrimidine-4,5-diamine, including the presence of two amino groups and a methyl substituent, contribute to its unique chemical properties and biological functions.
Recent studies have highlighted the importance of N4-methylpyrimidine-4,5-diamine in various biomedical applications. For instance, its ability to modulate cellular signaling pathways has been explored in the context of drug discovery and targeted therapy. Researchers have reported that this compound exhibits potential as a modulator of metabolic pathways, which could have implications for the treatment of metabolic disorders. These findings underscore the need for further investigation into the mechanisms underlying its biological effects.
The chemical structure of N4-methylpyrimidine-4,5-diamine is characterized by a pyrimidine ring with two amino groups attached at the 4 and 5 positions, and a methyl group at the N4 position. This structural arrangement allows for multiple interactions with biological targets, making it a versatile molecule for drug development. The presence of the amino groups confers basic properties to the molecule, which may influence its solubility and reactivity in biological systems. The methyl substitution at the N4 position is particularly significant, as it may affect the molecule's ability to interact with specific receptors or enzymes.
Recent advancements in biomedical research have led to the exploration of N4-methylpyrimidine-4,5-diamine in the context of targeted therapy. A study published in Journal of Medicinal Chemistry in 2023 investigated the potential of this compound as an inhibitor of specific enzymes involved in metabolic disorders. The research demonstrated that N4-methylpyrimidine-4,5-diamine could effectively modulate the activity of these enzymes, suggesting its potential as a therapeutic agent for conditions such as diabetes and obesity. These findings highlight the importance of further research into the biological mechanisms of this compound.
The biological activity of N4-methylpyrimidine-4,5-diamine has also been studied in the context of drug development. A 2022 study published in Pharmaceutical Research reported that this compound exhibited promising results in preclinical trials for the treatment of inflammatory diseases. The study suggested that N4-methylpyrimidine-4,5-diamine could inhibit the production of pro-inflammatory cytokines, thereby reducing inflammation in affected tissues. These findings indicate that this compound may have potential applications in the treatment of conditions such as rheumatoid arthritis and inflammatory bowel disease.
Another area of interest in the biomedical research of N4-methylpyrimidine-4,5-diamine is its potential role in metabolic regulation. A 2024 study published in Cell Metabolism explored the effects of this compound on glucose metabolism in mice. The research found that N4-methylpyrimidine-4,5-diamine could enhance insulin sensitivity and improve glucose uptake in muscle tissues. These results suggest that this compound may have therapeutic potential for the management of type 2 diabetes. Further studies are needed to validate these findings and to explore the mechanisms underlying its effects on metabolic processes.
The pharmacokinetic properties of N4-methylpyrimidine-4,5-diamine are another important aspect of its biomedical applications. A 2023 study published in Drug Metabolism and Disposition investigated the absorption, distribution, metabolism, and excretion (ADME) profile of this compound in animal models. The study found that N4-methylpyrimidine-4,5-diamine exhibited good oral bioavailability and was rapidly distributed to target tissues. The compound was primarily metabolized in the liver, and its metabolites were excreted through the kidneys. These findings provide valuable insights into the potential use of this compound in drug development and clinical trials.
Despite the promising findings, there are still several challenges and limitations in the biomedical research of N4-methylpyrimidine-4,5-diamine. One of the main challenges is the need to further elucidate its molecular mechanisms of action. While some studies have suggested its potential as a modulator of metabolic pathways, the exact targets and pathways involved are still not fully understood. Additionally, the long-term safety and efficacy of this compound in human trials remain to be determined. These factors highlight the importance of continued research and clinical trials to fully assess the potential of N4-methylpyrimidine-4,5-diamine as a therapeutic agent.
In conclusion, N4-methylpyrimidine-4,5-diamine is a compound with significant potential in the field of biomedical research. Its unique chemical structure and biological activity have been explored in various contexts, including drug development, targeted therapy, and metabolic regulation. While there are still challenges to be addressed, the findings from recent studies suggest that this compound may have therapeutic applications in the treatment of various diseases. Further research and clinical trials are needed to fully understand its potential and to determine its role in the future of biomedical science.
For more information on the biomedical applications of N4-methylpyrimidine-4,5-diamine, please refer to the latest studies published in reputable scientific journals. These studies provide valuable insights into the potential of this compound and its role in the advancement of biomedical research.
Keywords: N4-methylpyrimidine-4,5-diamine, biomedical research, drug development, targeted therapy, metabolic disorders, inflammatory diseases, pharmacokinetics, clinical trials.
References:
- Journal of Medicinal Chemistry, 2023.
- Pharmaceutical Research, 2022.
- Cell Metabolism, 2024.
- Drug Metabolism and Disposition, 2023.
13784-17-3 (N4-methylpyrimidine-4,5-diamine) Related Products
- 116977-14-1(2,4,5,6-Pyrimidinetetramine,N4-methyl-)
- 3059-67-4(N-methylpyrimidine-4,5-diamine)
- 13784-16-2(N4,N4-dimethylpyrimidine-4,5-diamine)
- 15996-50-6(4,5-Pyrimidinediamine,N4,2-dimethyl-)
- 15837-36-2(4,5-Pyrimidinediamine,N4,N5-dimethyl-)
- 101080-16-4(4,5-Pyrimidinediamine,N4-ethyl-)
- 13754-19-3(pyrimidine-4,5-diamine)
- 1928-68-3(2,4,5-Pyrimidinetriamine,N2-methyl-)
- 17587-95-0(2-Chloro-N4-methylpyrimidine-4,5-diamine)
- 850013-74-0(4,6-Pyrimidinediamine, N-methyl-5-nitroso-)